8-K: Avalon GloboCare to Showcase KetoAir Breathalyzer at Keto Pa-LOU-za Conference

Avalon GloboCare will sponsor the Keto Pa-LOU-za 2024 Conference to showcase and sell their KetoAir breathalyzer device.

Summary

• Avalon GloboCare Corp. is sponsoring the Keto Pa-LOU-za 2024 Conference from October 11-13 in Louisville, KY.
• The company will showcase its KetoAir breathalyzer, a handheld device that monitors ketosis through breath analysis.
• Attendees will be able to see live demonstrations and purchase the KetoAir device and related accessories.
• The KetoAir device measures breath acetone concentration (BrAce) using nano-sensor technology.
• The device is designed to assess ketosis status and is available on both the Apple App Store and Google Play Store.
• Avalon, through its subsidiary Q&A Distribution LLC, has exclusive distribution rights for KetoAir in North America, South America, EU, and UK.

Sentiment

Score: 7

Explanation: The document is positive, highlighting a new product launch and market opportunity. However, it also includes standard risk disclosures, which temper the overall sentiment.

Positives

• The KetoAir device offers a user-friendly way to track ketosis without invasive blood tests.
• The conference provides an ideal platform to connect with individuals and key influencers in the ketogenic community.
• The company has exclusive distribution rights for KetoAir in key global markets.
• The device is available on both the Apple App Store and Google Play Store, increasing accessibility.

Risks

• The press release contains forward-looking statements which are subject to risks and uncertainties.
• Actual results may differ materially from those indicated by forward-looking statements due to various factors.
• General industry and market conditions, economic conditions, and governmental and public policy changes could impact results.

Future Outlook

The company aims to commercialize and distribute the KetoAir device and compete with other testing methods for determining ketosis. The company may elect to update forward-looking statements in the future, but disclaims any obligation to do so.

Management Comments

• David Jin, M.D., Ph.D., CEO of Avalon, stated that the conference provides an ideal platform to connect with individuals and key influencers who are committed to the ketogenic lifestyle.
• David Jin, M.D., Ph.D., CEO of Avalon, stated that the conference will highlight the innovative capabilities of KetoAir in supporting their health journey.

Industry Context

This announcement highlights Avalon's focus on the growing market for personalized health and wellness solutions, particularly in the ketogenic diet space. The company is leveraging a conference to promote its product directly to its target market.

Comparison to Industry Standards

• The KetoAir device competes with other methods of ketosis monitoring, such as blood tests and urine strips.
• Other companies in the health and wellness space, such as Abbott with their Freestyle Libre glucose monitoring system, also focus on user-friendly, at-home testing devices.
• The use of nano-sensor technology in the KetoAir device is a differentiating factor compared to traditional methods.
• The exclusive distribution rights in key global markets position Avalon to compete with other companies in the health and wellness space.

Stakeholder Impact

• Shareholders may view this announcement positively as it represents a new product launch and market opportunity.
• Customers interested in the ketogenic lifestyle will have access to a new tool for monitoring ketosis.
• Employees may be impacted by the increased activity related to the product launch and conference participation.

Next Steps

• Avalon will participate in the Keto Pa-LOU-za 2024 Conference from October 11-13.
• The company will showcase and sell the KetoAir device at the conference.
• Avalon will continue to commercialize and distribute the KetoAir device.

Key Dates

Keywords

KetoAir, breathalyzer, ketosis, ketogenic, diagnostics, Avalon GloboCare, healthcare, medical device, conference